In vitro methods for making a recombinant adenoviral genome, as well as kits
for
practicing the same and the recombinant adenovirus vectors produced thereby, are
provided. In the subject methods, the subject genomes are prepared from first and
second vectors. The first vector includes an adenoviral genome having an E region
deletion and three different, non-adenoviral restriction endonuclease sites located
in the E region. The second vector is a shuttle vector and includes an insertion
nucleic acid flanked by two of the three different non-adenoviral endonuclease
sites present in the first vector. Cleavage products are prepared from the first
and second vectors using the appropriate restriction endonucleases. The resultant
cleavage products are then ligated to produce the subject recombinant adenovirus
genome. The subject adenoviral genomes find use in a variety of applications, including
as vectors for use in a variety of applications, including gene therapy.